These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1811918)

  • 41. Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives.
    Woodson LC; Ames MM; Selassie CD; Hansch C; Weinshilboum RM
    Mol Pharmacol; 1983 Nov; 24(3):471-8. PubMed ID: 6633508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
    Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
    Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Med Clin (Barc); 2003 Jun; 121(1):1-5. PubMed ID: 12812701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
    Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
    Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
    Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thiopurine methyltransferase activity in the Jewish population of Israel.
    Lowenthal A; Meyerstein N; Ben-Zvi Z
    Eur J Clin Pharmacol; 2001 Apr; 57(1):43-6. PubMed ID: 11372589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.
    Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV
    Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfation of drugs and hormones in mid-gestation human fetus.
    Pacifici GM
    Early Hum Dev; 2005 Jul; 81(7):573-81. PubMed ID: 16009282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.
    Tai HL; Krynetski EY; Schuetz EG; Yanishevski Y; Evans WE
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6444-9. PubMed ID: 9177237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
    Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity.
    Reuther LO; Vainer B; Sonne J; Larsen NE
    Eur J Clin Pharmacol; 2004 Jan; 59(11):797-801. PubMed ID: 14634700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.
    Bo J; Schrøder H; Kristinsson J; Madsen B; Szumlanski C; Weinshilboum R; Andersen JB; Schmiegelow K
    Cancer; 1999 Sep; 86(6):1080-6. PubMed ID: 10491537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
    Otterness DM; Szumlanski CL; Wood TC; Weinshilboum RM
    J Clin Invest; 1998 Mar; 101(5):1036-44. PubMed ID: 9486974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.
    Dervieux T; Médard Y; Baudouin V; Maisin A; Zhang D; Broly F; Loirat C; Jacqz-Aigrain E
    Br J Clin Pharmacol; 1999 Dec; 48(6):793-800. PubMed ID: 10594482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of thiopurine S-methyltransferase (TPMT) activity by comparing various normalization factors: reference values for Estonian population using HPLC-UV assay.
    Oselin K; Anier K; Tamm R; Kallassalu K; Mäeorg U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):77-83. PubMed ID: 16517227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease.
    Bahrehmand F; Kiani A; Vaisi-Raygani A; Bashiri H; Zobeiri M; Moini A; Pourmotabbed T
    Acta Med Iran; 2017 Jun; 55(6):360-367. PubMed ID: 28843236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotyping of thiopurine methyltransferase using pyrosequencing.
    Okada Y; Nakamura K; Wada M; Nakamura T; Tsukamoto N; Nojima Y; Horiuchi R; Yamamoto K
    Biol Pharm Bull; 2005 Apr; 28(4):677-81. PubMed ID: 15802809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.
    Khalil MN; Erb N; Khalil PN; Escherich G; Janka-Schaub GE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):105-11. PubMed ID: 15897017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.